Liquidia Corporation (LQDA)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$88.59
+5.46%
Mkt Cap $7.51B
Analyst Ratings
No recent rating data.
Price Target (23 analysts)
$74.83
Range $60.00 – $109.00
Implied Upside
-15.5%
Consensus $74.83 vs current $88.59